Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Patent
1997-02-24
1999-01-05
Wax, Robert A.
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
4352523, 4353201, 536 235, 536 2432, C12P 2106, C12N 121, C12N 1563, C07H 2104
Patent
active
058561315
ABSTRACT:
The present invention provides a human selenoprotein (HSEL) and polynucleotides which identify and encode HSEL. The invention also provides genetically engineered expression vectors and host cells comprising the nucleic acid sequences encoding HSEL and a method for producing HSEL. The invention also provides for agonists, antibodies, or antagonists specifically binding HSEL, and their use, in the prevention and treatment of diseases associated with expression of HSEL. Additionally, the invention provides for the use of antisense molecules to polynucleotides encoding HSEL for the treatment of diseases associated with the expression of HSEL. The invention also provides diagnostic assays which utilize the polynucleotide, or fragments or the complement thereof, and antibodies specifically binding HSEL.
REFERENCES:
Database EST-STS, Accession No. H61256, Hiller et al., The Washington University-Merck EST Project, Oct. 6, 1995.
Vendeland, S. C. et al. "Rat skeletal muscle selenoprotein W: cDNA clone and mRNA modulation by dietary selenium" Proceedings of the National Academy of Sciences, USA (Sep. 1995), vol. 92, No. 19, pp. 8749-8753.
Georgiou, G. "Optimizing the production of recombinant proteins in microoganisms" AlChE Journal (Aug. 1988), vol. 34, No. 8, pp. 1233-1248.
Medina, D. et al., "Current ideas on selenium as a chemopreventive agent." Pathol.Immunopathos.Res. (1988) 7:187-199.
Morris, J.G. et al., "Selenium deficiency in cattle associated with Heinz bodies and anemia." Science (1984) 223:491-493.
Batist, et al., "Cardiac and red blood cell glutathione peoxidase: results of a prospective randomized trial in patients on total parenteral nutrition." Cancer Res. (1985) 45:5900-5903.
Ip, C. "The chemopreventive role of selenium in carcinogenesis." Adv.Exp.Med.Biol. (1986) 206:431-447.
Holmberg, S.B et al., "Chemopreventive of cancer. Epidemiology and basic research to new directions." Nord.Med. (1991) 106:86-89. (Non-English article with abstract in English).
Zachara, B.A. "Mammalian selenoproteins." J. Trace Elem.Electrolytes Health Dis. (1992) 6:137-151.
Mandel, S.J. et al., "Cloning and in vitro expresion of the human selenoprotein, type I iodothyronine deiodinase." J.Clin.Endocrinol.Metab. (1992) 75:1133-1139.
Gladyshev, V.N. et al., "Selenocysteine identified as the penultimate C-terminal residue in human T-cell thioredoxin reductase, corresponds to TGA in the human placental gene." Proc.Natl.Acad.Sci.USA (1996) 93:6146-6151.
Zhu, Z. et al., "Effect of selenium on malignant tumor cells of brain." Biol.Trace Elem.Res. (1995) 49:1-7.
Morrison, D.G. et al., "Intracellular 58-kd selenoprotein levels correlate with inhibition of DNA synthesis in mammary epithelial cells." Carcinogenesis (1988) 9:1801-1810.
Goli Surya K.
Hillman Jennifer L.
Billings Lucy J.
Incyte Pharmaceuticals Inc.
Lau Kawai
Mohan-Peterson Sheela
Wax Robert A.
LandOfFree
Human selenoprotein does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human selenoprotein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human selenoprotein will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-861219